Chapter 1060: Cost is priceless

"Pick up an apocalyptic world (
In the third batch of quotations, there are many top pharmaceutical companies in it, and even many individuals in it.
Many of these pharmaceutical companies have obtained exclusive agency rights in the first and second rounds of auctions, but they still have not stopped competing for exclusive agency rights in other regions.
For a company like Ito Group, 2.5 billion US dollars have been spent. Do you still care about 100 million US dollars?
As long as the exclusive agency rights in a certain region are obtained, it means that another batch of general cancer treatment drugs can be obtained.
After getting the general cancer medicine, who knows where these general cancer medicines are used?
For this loophole, does Xingchen Pharmaceutical know about it?
Of course I know, but Star Pharma has not stopped their practices. They compete with each other, and it is Star Pharma that ultimately benefits. Why don't you make money if you have money?
For those top group companies competing for the third batch, as long as they win exclusive agency rights in a certain region, their costs will be much lower.
Almost all of these things are on the facade, and anyone can participate.
The third and final batch, although the number is large, the competition is quite fierce.
At the last minute, the bidding prices of various countries had almost doubled, and the lowest prices had exceeded 200 million US dollars.
In the last minute, the bidding numbers scrolled wildly, and it was almost impossible to see what the price was.
No one knows what the final transaction price will be.
Even the top groups dare not assert that they will be able to win exclusive agency rights in a certain region.
Too much, it feels a bit unworthy, and less, it is a bit uncomfortable to be snatched away.
Ding.
The third batch of transaction prices are freshly released.
Everyone was stunned by the price in front of them.
The highest in a country, reached 635 million US dollars.
It is necessary to know that the price in the second round is only half a billion US dollars, and the 635 million US dollars is more than 100 million US dollars more than the second round price. You can see the crazy behavior of these investors.
The difference between the second and third rounds of exclusive agency rights lies in the supply of general cancer treatment drugs.
The annual supply of the first round of general cancer treatment drugs is 1,200 copies.
The annual supply of the second round of general cancer treatment drugs is 600 copies.
The supply of the third round of general-purpose cancer drugs in one year is only 300 copies.
The cost of the exclusive agency fee was evenly divided among each generic cancer drug, and the price was doubled.
However, there are not many of the third round of over 500 million US dollars, most of which are around 300 million US dollars.
The lowest one is only $265 million.
Three rounds of exclusive agency auctions ended successfully.
This auction lasted for three hours, but the turnover exceeded 100 billion US dollars.
Regarding the hot spots of cancer general medicine auctions, it has been firmly occupying the list of major entertainment platforms.
"Xingchen Pharmaceutical is too profitable? A small exclusive agency with a revenue of more than 100 billion U.S. dollars, plus the cancer treatment generic drugs sold to them, the revenue is probably more than 200 billion U.S. dollars, right? I know, I was shocked, an auction directly created a Fortune 500 company."
"I am not jealous of the fact that Xingchen Pharmaceutical can make so much money. It has solved a terminal illness that has plagued human history for many years. It is absolutely deserved to be able to obtain this benefit."
"I have no objection to the fact that Star Pharmaceuticals makes so much money. It's just that the exclusive agency fees are so expensive that they are evenly distributed to each generic cancer drug. I'm afraid it will cost more than three million US dollars?"
"More than that, according to the published situation, the average price of a general cancer treatment in Sam's country is nearly four million US dollars. I am afraid that few people can afford it."
"We ordinary people should not worry about this anymore. Even if their conscience finds that it drops to one million dollars, people who cannot be cured can still not be cured. But for those who are rich, it is equivalent to giving them hope of life. ."
"It would be great if Star Pharma had reduced the price to the same level as China, so that most people would be able to afford it."
"Fart, the reason why Huaxia people can buy one with 200,000 yuan is because of the benefits provided to Huaxia people by Xingchen Pharmaceutical, which really means that Xingchen Pharmaceutical does not have to make money? I don't know how much Xingchen Pharmaceutical has invested in research and development. funds.
However, from the investment of Pfizer Pharmaceuticals, Ito Pharmaceuticals and other large companies in the research and development of tumor treatment drugs, the investment of Star Pharma can be estimated.
Pfizer's research and development costs for new drugs average around US$950 million.
Ito Pharmaceutical’s research and development costs for new drugs average around US$1.1 billion.
The above-listed are world-famous pharmaceutical companies. The average cost of each of their new drugs is as high as one billion U.S. dollars. This cost can be reduced only with their high-end technology.
Look at the research and development costs of other pharmaceutical companies, most of which are as high as US$1.5 billion or even US$2 billion.
The research and development cost of drugs is terribly high. This is still the research and development of ordinary drugs. For such an epoch-making product as general-purpose cancer treatment, the investment of Star Pharmaceuticals on it may not be less than 10 billion U.S. dollars~EbookFREE.me~ or even More.
Star Pharma has spent so much cost to develop a general cancer treatment drug, why do you think that the price will be reduced? "
When this netizen replied, he also published the research and development costs of the world's well-known pharmaceutical companies on the Internet. He didn't know who this person was. He had such a great skill to obtain such information.
The information uploaded by this netizen is not just a simple introduction of costs, but more of the internal costs of the pharmaceutical company.
Generally speaking, such documents related to the cost of medicines are strictly confidential documents, and it is impossible for ordinary people to obtain them.
Most of the people on the Internet are people who eat melons. Seeing the information listed by this netizen, they subconsciously believe it.
When you think of the event being forced to live broadcast not long ago, it is not that surprising.
For them, cancer is very close and far away, so it's better to eat melons to make them feel better.
In his free time, Liu Mingyu also visits the major entertainment platforms, brushes Douyin, and uses Xingchen Assistant.
After seeing this netizen's series of analyses, Liu Mingyu couldn't help but give him a thumbs up. The analysis was too right.
If the general medicine for cancer treatment is really studied from scratch, let alone ten billion dollars, I am afraid that adding zero will not be enough.
Don’t you see, since cancer appeared in human society in the last century, major pharmaceutical companies have spent more than 100 billion U.S. dollars to develop corresponding specific drugs.
Five hundred billion dollars, or even one trillion dollars, can't be beaten.
However, the research and development cost of general cancer drugs is much lower than this netizen's analysis.
Well, of course, this has to get rid of the cost of the energy spar, after all, there is no price for the energy spar, and no one knows how much it should be.
If you count the energy spar, the cost is priceless.